Shanmugam Muthusamy 4
4 · ANI PHARMACEUTICALS INC · Filed Aug 22, 2025
Insider Transaction Report
Form 4
Shanmugam Muthusamy
DirectorHEAD OF R&D, COO-NOVITIUM OPS
Transactions
- Sale
Common Stock
2025-08-20$90.27/sh−47,012$4,243,773→ 484,908 total(indirect: By LLC) - Sale
Common Stock
2025-08-21$90.44/sh−52,988$4,792,235→ 431,920 total(indirect: By LLC)
Holdings
- 92,588
Common Stock
- 5,000(indirect: By LLC)
Common Stock
Footnotes (4)
- [F1]The shares were sold in multiple trades at prices ranging from $89.21 to $90.83. The price reported above reflects the weighted average sales price.
- [F2]The reporting person holds voting and dispositive power over the shares held by Esjay LLC.
- [F3]The shares were sold in multiple trades at prices ranging from $89.90 to $91.44. The price reported above reflects the weighted average sales price.
- [F4]The Reporting Person holds voting and dispositive power over the shares held by SS Pharma LLC.